Julie Ann Justo
@julie_justo
Followers
6K
Following
22K
Media
555
Statuses
6K
ID Stewie & Clinical Pharmacist @DartmouthHealth 👩🏻⚕️💊| Co-Host of Breakpoints Podcast @SIDPharm 🎙️ | all-around #idgeek 🦠👩🏻🔬🧫
Lebanon, NH
Joined March 2015
Finally playing Defenders of Soma & I have a classic decision to make. add tobra or a FQ for empiric double coverage against an unknown pathogen? 🦠🤔🦠 Each use accrues resistance in the game 😂 #idgeeks #healingblade
11
9
107
RT @ABsteward: Taxonomy shift 🚨.Candida auris has been reclassified as Candidozyma auris (C auris ) to reflect its distinct genetic profile….
0
43
0
RT @Billicillin: The grip cefdinir has on folks is unreal. It’s the catfish of the beta-lactams!! Fight the good fight!! #DownWithCefdinir….
0
7
0
✨New #SIDP #Breakpoints episode out today🎙️🎧 #IDTwitter #TwitteRx. Hear how experts turned a clindamycin shortage & other opportunities into modernizing abx for OB-Gyn infxns. 🍋➡️🥤. Thx to Drs. Pam Bailey, Ben Ereshefsky, & Amy Crockett!. 🔗:
0
3
22
RT @ABsteward: 🆕💫 Systematic Review and Meta-Analysis @CMIJournal @ConnorProsty @DrToddLee @DrEmilyMcD @syctong.30 observational studies( S….
clinicalmicrobiologyandinfection.org
There is debate on whether cefazolin or antistaphylococcal penicillins should be the first-line treatment for methicillin-susceptible Staphylococcus aureus (MSSA) bacteraemia. Ongoing trials are...
0
22
0
RT @bryan_p_white: SNAP/COLCEBA trial session starting now @syctong @Josh_S_Davis @ABsteward .Staph aureus causes 1 million deaths per year….
0
35
0
RT @nbennett04: Trigger warning ⚠️ . Ceftriaxone isn’t de-escalation in many clinical scenarios.
0
12
0
RT @Josh_S_Davis: Excited to announce that we randomised our first patient into the #ROADMAPtrial today! First of thousands, answering impo….
roadmaptrial.com
Explore our website to learn more about our trial, team, and how you can get involved in shaping the future of PJI treatment.
0
10
0
So fun to join the ever-entertaining & educational duo Jame & Callum for the latest episode of @IDiots_pod with my girl, @ErinMcCreary, to talk about our fav topic: gram-negative resistance!. Check it out👇🏻🙃🎧.
IT’S A BREAKPOINTS BREAKOUT!!!. This week @ErinMcCreary & @julie_justo from @SIDPharm #Breakpoints podcast join Callum & Jame to show ‘em how it’s done and discuss the IDSA Difficult-to-Treat Gram Negative guidance!!. #IDTwitter.
0
1
5
0
8
0
RT @ABsteward: 🔥A sneak peak on the upcoming IDSA guidelines for cUTI🔥.Public Comment: IDSA Guideline on Management and Treatment of Compli….
0
94
0
RT @ABsteward: Breaking news🔥.US FDA approves EMBLAVEO (aztreonam and avibactam) for complicated intra-abdominal infections (cIAI) in adul….
0
36
0
Led by the incredible Dr. Pam Bailey! Excellent statewide stewardship work by @ASC_SCarolina.
@julie_justo @BBookstaver_USC @HanaWinders et al: Appropriateness of ambulatory antibiotic prescribing in South Carolina, 2012–2017
0
0
0
🚨 New @SIDPharm #Breakpoints Episode! 🎙️. Join Drs. @Cortes_Penfield, @JessieLSeidel, @Kerry_LaPlante, & me to discuss biofilms in PJIs. 🧫, what the lab tells us about the best drugs 💊, & the innovative non-pharmacological strategies (more than just 🦴 cement!). #IDTwitter
1
9
29
RT @idpharmd: Who will steer the antibiotic stewardSHIP ship when I am 80? My most creative, & thought provoking @ASHE_Journal - https://t.….
cambridge.org
Who will steer the antibiotic stewardSHIP ship when I am 80? - Volume 5 Issue 1
0
18
0
Heartbreaking news about the great @mnneely and his family home in the Eaton fire. 💔 Pls consider donating. 👇🏻 @SIDPharm #IDTwitter #TwitteRx.
The California fires are obviously horrible. In the Infectious Diseases and Pharmacometrics community, our college @mnneely lost his house. His family is safe, but if you wish to contribute to helping him get his life back to normal, you can do so here:.
0
0
1
Finally! Some helpful material to educate the public on the penicillin allergy myth…from one of my fav podcasts 🎙️, @Freakonomics👇🏻 #IDTwitter #TwitteRx . 🔗:
podcasts.apple.com
Podcast Episode · Freakonomics Radio · 01/10/2025 · 1h 4m
4
29
77